Trial intelligence / Profile preview

Factors of Treatment Response in MDD

NCT00200902Phase 4Completed

Sponsor
University of California, Los Angeles
Start
Aug 2005
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of venlafaxine, duloxetine, escitalopram in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started Aug 2005; status: completed.

02

Drugs

venlafaxineduloxetineescitalopram
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00200902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00200902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call